Published in Int Cardiovasc Res J on December 01, 2013
Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases (2015) 0.82
Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort study. Medicine (Baltimore) (2015) 0.79
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology (2000) 9.74
The model for end-stage liver disease (MELD). Hepatology (2007) 4.81
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Anesthesia for patients with congenital long QT syndrome. Anesthesiology (2005) 2.85
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation (2000) 2.10
Cardiovascular complications of cirrhosis. Gut (2008) 2.06
QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol (2006) 1.89
Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology (1996) 1.59
Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology (1996) 1.47
Pediatric end-stage liver disease score in acute liver failure to assess poor prognosis. J Pediatr Gastroenterol Nutr (2012) 1.45
Therapy insight: Cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol (2006) 1.19
Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int (2003) 1.17
QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab (1987) 1.16
Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol (2006) 1.08
Alterations in QT interval in patients undergoing living donor liver transplantation. Transplant Proc (2011) 0.88
Correlation between anthropometrics measurements, prealbumin level and transferin serum with Child-Pugh classification in evaluating nutritional status of liver cirrhosis patient. Acta Med Indones (2005) 0.86
Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation. Jpn Heart J (1998) 0.86
Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease. Clin Cardiol (2010) 0.82
Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease. Dig Dis Sci (2005) 0.82
Evolution of the plasma concentration of norepinephrine in cirrhotic patients during liver transplantation. Transplant Proc (2000) 0.79
Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation. Transplant Proc (1999) 0.79
QT interval duration remains a major risk factor in long QT syndrome patients. J Am Coll Cardiol (2006) 0.78
Left ventricular volumes in liver cirrhosis. Dig Liver Dis (2001) 0.78
Evaluation of electrocardiographic changes after arterial switch operation. Int Cardiovasc Res J (2014) 0.76
QT Dispersion and T Wave Peak-to-end Interval Dispersion in Children with Kawasaki Disease. Int Cardiovasc Res J (2013) 0.75